Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition ...

Please provide your email address to receive an email when new articles are posted on . Blood dendritic cell antigen 2 and neonatal fragment crystallizable receptor are two novel strategies in lupus ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio SCOTTSDALE, Ariz. — A novel therapeutic ...

The study showed that rozanolixizumab, a drug made of monoclonal antibodies like the one shown above, blocked the movement of ...

Immunosuppressive medications. Drugs like corticosteroids or azathioprine work by calming the immune system and reducing the ...

All of the shares to be sold in the underwritten public offering are being offered by Viridian. The offering is expected to close on or about October 23, 2025, subject to customary closing conditions.

This article is based on a poster originally authored by Zachary Fagiani, Rebecca L. Rich, Noah T. Ditto, Larry Yu, Michael Friedman, Glory Gao, Spencer Chiang and Jane Liu from ACROBiosystems..

Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to ...